Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis

M Garcia-González1, D Boixeda, D Herrero

  • 1Servicio de Gastroenterologia, Hospital Ramón y Cajal, Madrid, Spain.

Gastroenterology
|August 1, 1993
PubMed

Insights

Cirrhotic patients exhibit impaired leukocyte function, increasing infection risk. Granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrated in vitro improvement in phagocytosis and chemotaxis for these patients.

Area of Science:

  • Immunology
  • Hematology
  • Gastroenterology

Background:

  • Cirrhosis is associated with impaired leukocyte function and high infection rates.
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances phagocytic cell activity.
  • Clinical applications of GM-CSF are being investigated for immune support.

Purpose of the Study:

  • To evaluate the in vitro effects of GM-CSF on leukocyte function in cirrhotic patients.
  • To assess phagocytosis, phagocytic index, and chemotaxis in polymorphonuclear leukocytes.
  • To compare leukocyte function in compensated and infected cirrhotic patients with healthy controls.

Main Methods:

  • Polymorphonuclear leukocytes (PMNs) from 21 cirrhotic patients and 14 healthy donors were analyzed.
  • Basal PMN functions were tested, followed by incubation with GM-CSF (10 ng/mL).
  • Phagocytosis against Candida albicans and chemotaxis via Boyden chamber were assessed.

Main Results:

  • Cirrhotic leukocytes showed significantly lower basal phagocytosis and chemotaxis compared to controls.
  • GM-CSF stimulation increased phagocytosis and chemotaxis in non-infected cirrhotic patients.
  • GM-CSF also improved phagocytic index, phagocytosis, and chemotaxis in cirrhotic patients with peritonitis.

Conclusions:

  • Leukocyte function is defective in both compensated and infected cirrhotic patients.
  • GM-CSF shows potential for in vitro enhancement of immune cell function in cirrhosis.
  • Further research into GM-CSF's therapeutic role in cirrhotic patients is warranted.
Abstract

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...